tiprankstipranks
Advertisement
Advertisement

IN:SUNPHARMA Stock Latest News

Sun Pharma Publishes Postal Ballot and E-Voting Notices for Shareholders
Company AnnouncementsSun Pharma Publishes Postal Ballot and E-Voting Notices for Shareholders
4d ago
Sun Pharma, Philogen Advance Nidlegy After Mixed Fibromun Trial Results
PremiumCompany Announcements
Sun Pharma, Philogen Advance Nidlegy After Mixed Fibromun Trial Results
16d ago
Sun Pharma’s GL0034 Diabetes Trial: Early-Stage Data Catalyst in a Crowded Metabolic Market
PremiumCompany Announcements
Sun Pharma’s GL0034 Diabetes Trial: Early-Stage Data Catalyst in a Crowded Metabolic Market
2M ago
Sun Pharma Advances GL0034 Diabetes Program With Kidney Function Study, Supporting Long-Term Pipeline Story
PremiumCompany Announcements
Sun Pharma Advances GL0034 Diabetes Program With Kidney Function Study, Supporting Long-Term Pipeline Story
2M ago
Sun Pharma Publishes Q3 FY26 Unaudited Results Notice in Newspapers
PremiumCompany Announcements
Sun Pharma Publishes Q3 FY26 Unaudited Results Notice in Newspapers
2M ago
Sun Pharma’s INSPIRE 1 Psoriatic Arthritis Trial Nears Key Data Milestone
PremiumCompany AnnouncementsSun Pharma’s INSPIRE 1 Psoriatic Arthritis Trial Nears Key Data Milestone
3M ago
Sun Pharma Rolls Out UNLOXCYT in U.S. for Advanced Skin Cancer Patients
Premium
Company Announcements
Sun Pharma Rolls Out UNLOXCYT in U.S. for Advanced Skin Cancer Patients
3M ago
Sun Pharma’s Baska Facility Receives OAI Classification from US FDA
Premium
Company Announcements
Sun Pharma’s Baska Facility Receives OAI Classification from US FDA
4M ago
Sun Pharma to Invest INR 3,000 Crores in New Manufacturing Facility
PremiumCompany Announcements
Sun Pharma to Invest INR 3,000 Crores in New Manufacturing Facility
4M ago
Sun Pharma’s New Study on Actinic Keratosis Treatment: What Investors Need to Know
PremiumCompany Announcements
Sun Pharma’s New Study on Actinic Keratosis Treatment: What Investors Need to Know
6M ago
Sun Pharma’s New Clinical Trial: A Potential Game-Changer for Actinic Keratosis Treatment
PremiumCompany Announcements
Sun Pharma’s New Clinical Trial: A Potential Game-Changer for Actinic Keratosis Treatment
6M ago
Sun Pharma’s Alopecia Areata Study: A Potential Game Changer?
PremiumCompany Announcements
Sun Pharma’s Alopecia Areata Study: A Potential Game Changer?
6M ago
Sun Pharma’s Composite Scheme of Arrangement Approved by NCLT
PremiumCompany AnnouncementsSun Pharma’s Composite Scheme of Arrangement Approved by NCLT
6M ago
Sun Pharma’s Sonidegib Study Completion: A Boost for Oncology Market Presence
Premium
Company Announcements
Sun Pharma’s Sonidegib Study Completion: A Boost for Oncology Market Presence
7M ago
Sun Pharma’s Halol Facility Faces FDA Compliance Challenges
Premium
Company Announcements
Sun Pharma’s Halol Facility Faces FDA Compliance Challenges
7M ago
Sun Pharma Announces Q1 Financials and Board Restructuring
PremiumCompany Announcements
Sun Pharma Announces Q1 Financials and Board Restructuring
9M ago
Sun Pharma’s New Study on Tildrakizumab: A Potential Game Changer for Genital Psoriasis
PremiumCompany Announcements
Sun Pharma’s New Study on Tildrakizumab: A Potential Game Changer for Genital Psoriasis
9M ago
Sun Pharma’s Promising Phase 3 Study on Genital Psoriasis Treatment
PremiumCompany Announcements
Sun Pharma’s Promising Phase 3 Study on Genital Psoriasis Treatment
9M ago
Sun Pharma’s Tildrakizumab Study: A Promising Step in Genital Psoriasis Treatment
PremiumCompany Announcements
Sun Pharma’s Tildrakizumab Study: A Promising Step in Genital Psoriasis Treatment
9M ago
Sun Pharma’s Promising Phase 3 Study on Tildrakizumab for Genital Psoriasis
PremiumCompany AnnouncementsSun Pharma’s Promising Phase 3 Study on Tildrakizumab for Genital Psoriasis
9M ago
Sun Pharma’s Sonidegib Safety Study: Key Insights for Investors
Premium
Company Announcements
Sun Pharma’s Sonidegib Safety Study: Key Insights for Investors
10M ago
Sun Pharma’s Tildrakizumab Study: A Potential Game-Changer for Psoriatic Arthritis
Premium
Company Announcements
Sun Pharma’s Tildrakizumab Study: A Potential Game-Changer for Psoriatic Arthritis
10M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >